2026 Robert A. Nathan: Immunology Researcher – H-Index, Publications & Awards

Overview

Robert A. Nathan is affiliated with the University of Colorado Colorado Springs in the United States. Their research primarily centers on pulmonary and respiratory medicine, with a focus on asthma and respiratory diseases.

Their recent publications cover various aspects of asthma treatment and respiratory drug delivery. Notable papers include the 2020 study "Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial" published in The Lancet Respiratory Medicine and the 2024 article "Characterization of Moderate and Severe Asthma Exacerbations in the CAPTAIN Study" in The Journal of Allergy and Clinical Immunology In Practice.

Additional research articles comprise:

"A phase IIb, randomised, parallel-group study: the efficacy, safety and tolerability of once-daily umeclidinium in patients with asthma receiving inhaled corticosteroids" (2020, Respiratory Research)
"Serious Asthma Outcomes and Asthma Exacerbations with Maintenance on Inhaled Corticosteroid (Mometasone Furoate)/Long-Acting Beta Agonist (Formoterol) Combination Compared to Step Down to Mometasone Monotherapy" (2020, The Journal of Allergy and Clinical Immunology In Practice)
"Once-daily, single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) versus FF/VI in inadequately controlled asthma: the CAPTAIN study" (2020, Journal of Allergy and Clinical Immunology)

Their frequent co-authors include Nicola A. Hanania, Edward Kerwin, Huib A.M. Kerstjens, Zelie Bailes, and Louis-Philippe Boulet.

Robert A. Nathan has published multiple papers in several notable journals, such as:

CHEST Journal
The Journal of Allergy and Clinical Immunology In Practice
Journal of Allergy and Clinical Immunology
The Lancet Respiratory Medicine
Respiratory Research

Their scientific work predominantly addresses the following research topics:

Asthma and respiratory diseases
Respiratory and cough-related research
Inhalation and respiratory drug delivery
Chronic obstructive pulmonary disease (COPD) research

The fields of study connected to Robert A. Nathan's output are medicine broadly, with a focus on pulmonary and respiratory medicine as well as physiology.

In addition to research articles, Robert A. Nathan has contributed to book publications, including "They went on together" (2020), published by the Japan Society of Medical Entomology and Zoology.

Best Publications

Development of the asthma control test: A survey for assessing asthma control

Robert A Nathan;Christine A Sorkness;Mark Kosinski;Michael Schatz

3742
Citations
Asthma Control Test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialists

Michael Schatz;Christine A. Sorkness;James T. Li;Philip Marcus

1553
Citations
The burden of allergic rhinitis.

Robert A Nathan

613
Citations
The diagnosis and management of sinusitis: A practice parameter update

Raymond G. Slavin;Sheldon L. Spector;I. Leonard Bernstein;Michael A. Kaliner

512
Citations
Prevalence of allergic rhinitis in the United States

Robert A. Nathan;Eli O. Meltzer;John C. Seiner;William Storms

362
Citations
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor

Hilary Longhurst;Marco Cicardi;Timothy Craig;Konrad Bork

251
Citations
Growth in asthmatic children treated with fluticasone propionate

David B. Allen;Edwin A. Bronsky;Craig F. LaForce;Robert A. Nathan

244
Citations
Objective monitoring of nasal patency and nasal physiology in rhinitis

Robert A. Nathan;Ron Eccles;Peter H. Howarth;Sverre K. Steinsvåg

238
Citations
Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey.

Eli O. Meltzer;Robert Nathan;Jennifer Derebery;Paul E. Stang

225
Citations
The prevalence of nasal symptoms attributed to allergies in the United States: findings from the burden of rhinitis in an America survey.

Robert A. Nathan;Eli O. Meltzer;Jennifer Derebery;Ulka B. Campbell

220
Citations
Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial.

Laurie A Lee;Zelie Bailes;Neil Barnes;Louis-Philippe Boulet

220
Citations
Efficacy and Safety of Fexofenadine Hydrochloride for Treatment of Seasonal Allergic Rhinitis

David I Bernstein;William F Schoenwetter;Robert A Nathan;William Storms

166
Citations
Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis.

Eli O. Meltzer;Thomas B. Casale;Robert A. Nathan;Ann K. Thompson

158
Citations
Asthma management and control in the United States: results of the 2009 Asthma Insight and Management survey.

Kevin R. Murphy;Eli O. Meltzer;Michael S. Blaiss;Robert A. Nathan

158
Citations
Quality of life and rhinitic symptoms: Results of a nationwide survey with the SF-36 and RQLQ questionnaires

Eli O. Meltzer;Robert A. Nathan;John C. Seiner;William Storms

142
Citations
The economic impact of allergic rhinitis

William Storms;Eli O. Meltzer;Robert A. Nathan;John C. Selner

140
Citations
Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction

R. A. Nathan;J. A. Bernstein;L. Bielory;C. M. Bonuccelli

129
Citations
Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control.

Robert A. Nathan;Steven W. Yancey;Kelli Waitkus-Edwards;Barbara A. Prillaman

127
Citations
Psychometric validation of the rhinitis control assessment test: a brief patient-completed instrument for evaluating rhinitis symptom control.

Michael Schatz;Eli O. Meltzer;Robert Nathan;M. Jennifer Derebery

125
Citations
Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis.

Nathan Ra;Bronsky Ea;Fireman P;Grossman J

119
Citations

Frequent Co-Authors

Eli O. Meltzer University of California, Berkeley

Kevin R. Murphy Boys Town

David I. Bernstein University of Cincinnati

Michael Schatz Kaiser Permanente

Ian D. Pavord University of Oxford

Harold S. Nelson National Jewish Health

William W. Busse University of Wisconsin–Madison

Jun-Tao Li Xiamen University

Bruce L. Zuraw University of California, San Diego

Jay M. Portnoy University of Missouri–Kansas City

External Links

Personal website of Robert A. Nathan

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in Immunology and seeking flexible education options, several online nursing degrees can complement this field. Many students begin with online ADN programs for non nurses, which offer a streamlined path for newcomers looking to enter healthcare and build foundational knowledge.

Once in nursing, professionals often explore advanced roles through accelerated RN to NP programs, enabling them to quickly transition into nurse practitioner roles that can interact closely with immunological research or patient care.

Specializing is another crucial step. For instance, the transition from family nurse practitioner (FNP) to acute care nurse practitioner (ACNP) can offer deeper expertise in critical care settings, which is often important when working with complex immunological conditions. Guidance on this shift can be found in the article about FNP to ACNP.

Career-wise, understanding which specialties are most lucrative is valuable. Immunology-related advanced nursing roles often align with some of the highest paid DNP specialties, highlighting a strong financial incentive alongside professional fulfillment.